Clinical and immunogenomic outcomes of consolidative cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint blockade.

被引：0
|
作者：
Reese, Stephen W. [1 ]
Jiang, Hui [1 ]
Kuo, Fengshen [1 ]
Wu, Chih-Ying [1 ]
Vuong, Lynda [1 ]
Mascareno, Eduardo [1 ]
Oparanozie, Arnold [1 ]
Motzer, Robert J. [1 ]
Voss, Martin H. [1 ]
Reznik, Eduard [1 ]
Reuter, Victor E. [1 ]
Coleman, Jonathan [1 ]
Russo, Paul [1 ]
Chen, Ying-Bei [1 ]
Kotecha, Ritesh R. [1 ]
Hakimi, A. Ari [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
720
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CLINICAL AND IMMUNOGENOMIC OUTCOMES OF CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT BLOCKADE
    Reese, Stephen W.
    Jiang, Hui
    Kuo, Fengshen
    Wu, Chih-Ying
    Vuong, Linda H.
    Mascareno, Eduardo A.
    Motzer, Robert
    Lee, Chung-Han
    Voss, Martin H.
    Reznik, Ed
    Reuter, Victor
    Coleman, Johnathan
    Russo, Paul
    Carlo, Maria
    Chen, Ying-Bei
    Kotecha, Ritesh R.
    Hakimi, Ari
    JOURNAL OF UROLOGY, 2023, 209 : E370 - E370
  • [2] COMPREHENSIVE IMMUNOGENOMIC EVALUATION OF PATIENTS UNDERGOING CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT BLOCKADE
    Reese, Stephen
    Yarlagadda, Vijay
    Wu, Chih-Ying
    Kuo, Fengshen
    Tang, Cerise
    Jiang, Hui
    Dawidek, Mark
    Vuong, Lynda H.
    Eismann, Lennert
    Motzer, Robert
    Reznik, Ed
    Reuter, Victor S.
    Coleman, Johnathan S.
    Russo, Paul S.
    Kotecha, Ritesh R.
    Leslie, Christina S.
    Chen, Yingbei
    Hakimi, A. Ari S.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1071 - E1071
  • [3] COMPREHENSIVE IMMUNOGENOMIC EVALUATION OF PATIENTS UNDERGOING CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT BLOCKADE
    Stephen, Reese
    Vijay, Yarlagadda
    Chih-Ying, Wu
    Fengshen, Kuo
    Cerise, Tang
    Hui, Jiang
    Vuong, Lynda H.
    Lennert, Eismann
    Robert, Motzer
    Voss, Martin H.
    Victor, Reznik Ed Reuter
    Johnathan, Coleman
    Paul, Russo
    Kotecha, Ritesh R.
    Christina, Leslie
    Yingbei, Chen
    Ari, Hakimi A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S44 - S44
  • [4] Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
    Hahn, Andrew W.
    Kotecha, Ritesh R.
    Viscuse, Paul V.
    Pieretti, Alberto C.
    Wiele, Andrew J.
    Jonasch, Eric
    Lee, Chung-Han
    Gao, Jianjun
    Zurita, Amado J.
    Shah, Amishi Y.
    Campbell, Matthew T.
    Sharma, Padmanee
    Motzer, Robert J.
    Russo, Paul
    Wood, Christopher G.
    Tannir, Nizar M.
    Voss, Martin H.
    Karam, Jose A.
    Hakimi, A. Ari
    Msaouel, Pavlos
    EUROPEAN UROLOGY FOCUS, 2023, 9 (05): : 734 - 741
  • [5] Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade
    Olsen, T. Anders
    Martini, Dylan J.
    Goyal, Subir
    Liu, Yuan
    Evans, Sean T.
    Magod, Benjamin
    Brown, Jacqueline T.
    Yantorni, Lauren
    Russler, Greta Anne
    Caulfield, Sarah
    Goldman, Jamie M.
    Harris, Wayne B.
    Kucuk, Omer
    Carthon, Bradley C.
    Master, Viraj A.
    Nazha, Bassel
    Bilen, Mehmet Asim
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents
    Jun Teishima
    Keisuke Goto
    Yohei Sekino
    Koji Mita
    Tetsutaro Hayashi
    Yasuhisa Hasegawa
    Masao Kato
    Mitsuru Kajiwara
    Masanobu Shigeta
    Satoshi Maruyama
    Yuichi Kadonishi
    Seiji Fujiwara
    Kanao Kobayashi
    Kousuke Asano
    Nobuyuki Hinata
    International Urology and Nephrology, 2022, 54 : 1225 - 1232
  • [7] Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents
    Teishima, Jun
    Goto, Keisuke
    Sekino, Yohei
    Mita, Koji
    Hayashi, Tetsutaro
    Hasegawa, Yasuhisa
    Kato, Masao
    Kajiwara, Mitsuru
    Shigeta, Masanobu
    Maruyama, Satoshi
    Kadonishi, Yuichi
    Fujiwara, Seiji
    Kobayashi, Kanao
    Asano, Kousuke
    Hinata, Nobuyuki
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (06) : 1225 - 1232
  • [8] PROGNOSTIC MODEL OF UPFRONT CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH IMMUNE-CHECKPOINT INHIBITORS AND/OR TYROSINE KINASE INHIBITORS
    Teishima, Jun
    Goto, Keisuke
    Sekino, Yohei
    Hayashi, Tetsutaro
    Hinata, Nobuyuki
    JOURNAL OF UROLOGY, 2022, 207 (05): : E169 - E170
  • [9] Cytoreductive nephrectomy (CN) for patients with metastatic sarcomatoid and/or rhabdoid (S/R) renal cell carcinoma (RCC) treated with immune checkpoint inhibitors (ICI)
    Hahn, A. W.
    Viscuse, P. V.
    Pieretti, A.
    Wiele, A. J.
    Jonasch, E.
    Gao, J.
    Zurita, A. J.
    Shah, A. Y.
    Campbell, M. T.
    Sharma, P.
    Wood, C. G.
    Tannir, N. M.
    Karam, J. A.
    Msaouel, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S699 - S700
  • [10] CYTOREDUCTIVE NEPHRECTOMY IS ASSOCIATED WITH IMPROVED SURVIVAL FOR SARCOMATOID METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED BEFORE OR AFTER SURGERY WITH IMMUNE CHECKPOINT INHIBITORS
    Paz, Lotan
    Jose, A. Karam
    Viraj, A. Master
    Philippe, E. Spiess
    Charles, C. Peyton
    Sarah, P. Psutka
    Jay, D. Raman
    Chiara, Mercinelli
    Edouard, Nicalse
    Nicholas, D. Robertson
    Barry, Sirard R.
    Amber, Jani
    Manley, Wade J.
    Brandon, Manley
    Dattatraya, Patil
    Glenn, O. Allen
    Surena, F. Matin
    Jason, Abel E.
    Daniel, D. Shapiro
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
12345